Clinical Trial Update: Long-term Pre-dialysis Extension in Europe and Asia Pacific [Phase 2]

View source ↗

Summary

Phase 2 long-term pre-dialysis extension trial conducted by Bayer in Europe and Asia Pacific for anemia related to chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• undisclosed

Snippet

Sponsor: Bayer | Conditions: Anemia, Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED